World leading structure accelerated lead discovery

Proteros is a biotech company focused on enabling lead discovery for challenging targets based on its unique expertise and understanding of protein and small molecule interactions. Co-founded in 1999 by Nobel Laureate Prof. Robert Huber, the company has established a global service business that includes 18 of the 20 largest pharmaceutical companies.

Discovery Services

Our performance is based on the best in class enabling platform for structure accelerated lead discovery.


Discovery Pipeline

Our proprietary lead discovery projects are focusing on disease relevant targets like kinases, epigenetic targets and GPCRs.

News